Introduction
Radionuclides find application in many fields. However, their major use is in medicine, both for diagnosis and therapy [cf . 1] . This is manifested by the International Symposium on Radiopharmaceutical Sciences, held biennially in some part of the world. The underlying principle of an *E-mail: s.m.qaim@fz-juelich. de. in vivo diagnostic application is that the radiation dose to the patient is as low as possible, compatible with the desired quality of imaging. This calls upon the use of very special radionuclides which can be detected efficiently from outside of the body. In general, short-lived γ -ray emitters or positron emitters are commonly used, the former finding application in Single Photon Emission Computed Tomography (SPECT) and the latter in Positron Emission Tomography (PET). In contrast, an internal therapeutic application requires that a certain amount of dose is specifically deposited in a malignant tissue. Thus for internal radiotherapy, radionuclides emitting corpuscular radiation (α-or β − particles, conversion and/or Auger electrons) are of interest.
The production of radionuclides for medical applications is carried out using both nuclear reactors and cyclotrons. The most commonly used SPECT radionuclide 99m Tc (T 1/2 = 6.0 h) is produced using a nuclear reactor. Its widespread use is mainly based on its convenient availability as a 99 Mo/ 99m Tc generator. Many of the cyclotron produced γ -ray emitting radionuclides, such as 67 Ga (T 1/2 = 78.3 h), 111 In (T 1/2 = 2.9 d), 123 I (T 1/2 = 13.2 h) and 201 Tl (T 1/2 = 73.1 h) also find application. They are commercially available. In recent years, however, the positron emitting radionuclides have been gaining more significance because PET has made it possible to quantitatively measure regional activities of a molecule (labelled with a positron emitter) with high sensitivity and a spatial resolution of a few mm. The commonly used short-lived organic positron emitters, viz.
11 C (T 1/2 = 20.3 min), 13 N (T 1/2 = 10.0 min), 15 O (T 1/2 = 2.0 min) and 18 F (T 1/2 = 110 min), are produced via lowenergy nuclear reactions at small-sized cyclotrons [cf . 2] . Besides those four organic positron emitters, two other short-lived positron emitters, namely 68 Ga (T 1/2 = 67.6 min) and 82 Rb (T 1/2 = 1.3 min), are produced via generator systems. Their respective long-lived parents 68 Ge (T 1/2 = 271 d) and 82 Sr (T 1/2 = 25.3 d) are produced through intermediate energy nuclear reactions. The whole PET technology (consisting of cyclotron, radionuclide production unit, and automated radiosynthesis apparatus) is now commercially available.
Among the therapeutic radionuclides, 131 I (T 1/2 = 8.02 d) is by far the most important, having an established place in the management of follicular thyroid carcinoma. The other radioiodine, 125 I (T 1/2 = 59.41 d), is used in Auger electron therapy. Several other reactor produced radionuclides, for example 32 P (T 1/2 = 14.3 d), 89 Sr (T 1/2 = 50.5 d), 90 Y (T 1/2 = 2.7 d) and 153 Sm (T 1/2 = 1.9 d), find application in palliative treatment. In recent years cyclotrons have also been increasingly used to produce some therapeutic radionuclides, in particular those emitting low energy but highly ionising radiation [cf . 3] .
Today, research work on radionuclides for nuclear medicine is carried out mainly in two directions:
1. Development of novel longer lived positron emitters. 2. Development of novel low-energy but highly ionising radiation emitters for internal radiotherapy.
This article deals with nuclear and radiochemical aspects of development of novel positron emitters. Those radionuclides can only be produced at cyclotrons (or accelerators).
With the increasing significance of PET in diagnostic nuclear medicine, the need for longer lived novel positron emitters, also termed as non-standard or innovative positron emitters, has been increasing, especially for studying slow metabolic processes [cf . 4] . Some aspects of their production have been considered [cf . [5] [6] [7] [8] . The present review discusses their production methodologies in more detail.
Fundamental considerations in development of novel positron emitters
The development of a novel positron emitter has to comply with certain constraints with respect to production possibilities (e.g. type of available cyclotron, yield of nuclear reaction to be used, enrichment of the target material, etc.). It calls upon interdisciplinary work comprising nuclear data measurement, high-current targetry, chemical processing, automation of the procedure and quality control of the product. Furthermore, its suitability for imaging, which is related to its decay characteristics, also needs to be demonstrated. A discussion of all those aspects, is given below, furnishing examples from a few recent investigations.
Nuclear data

Reaction cross section data
In cyclotron production of radionuclides, the reaction cross section data play a very important role [cf . 9, 10]. One needs the full excitation function of the nuclear process under consideration to be able to calculate the expected production yield with a reasonable accuracy. The data are needed mainly for the optimization of the production route, i.e. to maximize the yield of the desired product and to minimize the yields of the radioactive impurities. The calculated yield value of the desired product represents the maximum yield which can be expected from a given nuclear process. It should be pointed out that, whereas the non-isotopic impurities produced can be removed by chemical separations, the level of isotopic impurities can be suppressed only by using an enriched isotope as target material and/or by a careful selection of the particle energy range effective in the target, the latter information being derived from the respective excitation function. Besides isotopic impurities, isomeric impurities also need to be considered. Several novel medical radionuclides have isomeric states, which are rather disturbing. A few I) . The isomeric impurities cannot be controlled through a careful adjustment of the energy window (as mentioned above). Since the isomeric cross section ratio is primarily dependent on the type of reaction involved [cf . 11], it is essential to investigate all the possible production routes and then to choose the reaction and the energy range giving the best results. Obviously, nuclear data play here a very important role. Nuclear reaction cross section measurements performed [12, 13] in connection with the development of the positron emitter 120g I (T 1/2 = 1.35 h) provide a good example of the importance of nuclear data. The results on the 120 Te( p, xn) 119,120m,g I reactions [13] are shown in Fig. 1 . The energy range E p = 16 → 9 MeV appears to be optimum for the production of 120g I. Over this energy range the calculated thick target yield of 120g I is high (2.3 GBq/μA h), and the levels of the impurities are:
120m I (4.8%) and 119 I (4.4%). The impurity 119 I is not a problem. Being short-lived (T 1/2 = 19.1 min), it almost completely decays out during the separation of 120g I from the irradiated target. The isomeric impurity 120m I (T 1/2 = 53 min) is also shorter lived as compared to 120g I; its relative contribution would therefore decrease with the decay time. On the other hand, if the reaction 122 Te( p, 3n) 120m,g I is used [12] for the production of 120g I, with a calculated thick target yield of 120g I of 3.6 GBq/μA h over the energy range of E p = 37 → 32 MeV, the contribution of 120m I may amount up to 25%. Extensive nuclear data studies in connection with the development of innovative positron emitters have been carried out at the Forschungszentrum Jülich over the last 25 years. In most of the cases the low-energy ( p, n) reaction on a highly enriched target isotope was found to be ideal. The pertinent examples are: 64 Ni( p, n) 64 64 Cu, 86 Y and 124 I, the three most prominent novel positron emitters, the suggested ( p, n) reaction has become the method of choice for obtaining a high-purity product.
Besides the ( p, n) reaction, for several radionuclides other low and intermediate energy reactions, for example,
3 He, xn) and (α, xn), have also been investigated. Furthermore, in several cases, for example 64 Cu and 124 I, extensive comparisons of various production routes have been presented [cf . 8, 20] . Detailed evaluations of the data using nuclear model calculations and statistical fitting procedures have also been performed for several radionuclides [cf . [21] [22] [23] [24] . Thus the nuclear reaction cross section database for the production of innovative positron emitters appears to have considerably improved in recent years.
Decay data
In addition to the production data, some attention also needs to be paid to the radioactive decay data. Those data are of considerable significance in determining the quality of the image and the radiation dose deposited while using that radionuclide. In general, the decay data are fairly well known (cf. e.g. Evaluated Nuclear Structure and Decay Data File (ENSDF)). A problem with many of the novel positron emitters, however, is that the positron emission intensity is often rather low and not exactly known (cf . Report: IAEA-INDC(NDS)-0535 (2009)), thereby causing some uncertainty in the quantification of tomographic scans. Since decay schemes of many of the medically interesting radionuclides were determined using mixtures of radionuclides, often utilising detectors with rather poor resolution, it appears worthwhile to reinvestigate some of the special radionuclides in more detail using radiochemical techniques. Many of those medical radionuclides can now be produced with very high purities; the use of ultrapure sources should thus provide accurate information on the decay data as well. Some measurements on the positron emission intensities in the decay of 64 Cu, 76 Br, 120g I and 124 I have recently been carried out [25, 26] . Similar measurements on several other novel positron emitters also need to be performed.
High current targetry
The high current irradiation technology needed for medium to large scale production of a radionuclide is rather different from the low current irradiations performed for nuclear reaction cross section measurements. In fact the development of targetry for irradiations with intense charged particle beams constitutes one of the major efforts in cyclotron production of radionuclides [cf . 27] . The loss of energy of the charged particle in the target generates a lot of heat and, if high currents are used, the power density effective at a target may reach a high value (up to a few kW cm −2 ). An efficient heat transfer is thus one of the prime requirements in target construction. Several other considerations for target design are: (1) ease of chemical separation of the radioactive product, (2) high yield of the product, (3) radionuclidic purity, (4) chemical reactivity and specific activity of the desired product, and (5) recovery of enriched target material.
Whereas in the production of conventional short-lived organic positron emitters for PET, which are isotopes of light elements, gaseous and liquid targets are used, for the production of innovative positron emitters under consideration here, use is generally made of solid targetry [cf . 3, 27] , as it is done in the case of several SPECT radionuclides, e.g. 67 Ga, 111 In and 201 Tl. Occasionally a gas target is also used.
Irradiation of solid material is often carried out in a conventional target system, where the front side consists of a double foil window through which He gas flows for cooling the target material. The back side of the target is cooled by flowing water. The beam impinges on the target orthogonally. Rather commonly employed solid targetry today involves preparation of a relatively thick layer (up to a few hundred μm) of the target material via electrolytic deposition on a metal backing, and irradiations are performed with slanting beams. In other cases, where no elemental material is employed, suitably prepared alloys or intermetallic compounds are also used. Occasionally, the target material is an oxide which is spread on another metal, melted or sintered, and then used as an irradiation target.
A typical solid target system used, e.g. for the production of 55 Co and 64 Cu via the reactions 58 Ni( p, α) 55 Co and 64 Ni( p, n) 64 Cu, respectively, is shown in Fig. 2 [28] . The corresponding highly enriched nickel isotope is electroplated on an oval shaped gold backing which fits in a target holder designed to be exposed to the charged particle beam at an angle of 20
• . The target holder is cooled at the back by a water jet. Beam currents of about 30 μA are commonly used. With a better design of the system, beam currents of up to 300 μA could be put on the target. The same target set up has also been employed in the production of 124 I via the 124 Te( p, n)-reaction. In this case the target material 124 TeO 2 is melted on a Pt backing (rather than electroplating on gold) which is then attached to the target holder for irradiation.
For noble gases as target material, e.g. for the production of 38 83 Sr, respectively, a typical target system used is shown in Fig. 3 [29] . The conical shaped target has a double foil window in front, which is cooled by He gas. The other accessories form a complex system for safe handling of the highly enriched rare noble gas (filling the target, irradiation and its recovery for reuse). Beam currents of about 30 μA are used. Typical solid target system used for the production of 55 Co, 64 Cu or 124 I via the nuclear reactions 58 Ni( p, α) 55 Co, 64 Ni( p, n) 64 Cu and 124 Te( p, n) 124 I, respectively. In the first two cases, the highly enriched target material is electrolytically deposited on oval shaped gold backing; in the latter case 124 TeO 2 is melted on a Pt backing. The target fits in a target holder which is exposed to the proton beam at an angle of 20
• and is cooled at the back by a water jet (after Ref. [28] ).
Fig. 3.
Typical gas target system used for the production of 82m Rb via the nuclear reaction 82 Kr( p, n) 82m Rb. The conical shaped target has a double foil window in front, which is cooled by He gas. The other accessories form a compact system for safe handling of the highly enriched rare gas. The product 82m Rb is efficiently removed from the target inner wall by introducing steam, and is collected in water. The same system has been used also for the production of 38 K, 81 Rb or 83 Sr via the nuclear reactions 38 Ar( p, n) 38 K, 82 Kr( p, 2n) 81 Rb and 82 Kr( 3 He, 2n) 83 Sr, respectively; in each case proper target gas and charged particle beam energy have to be used (adapted from Ref. [29] ).
After irradiation, at first the enriched target gas is recovered. The product alkali or alkaline earth metal activity remains adsorbed on the inner walls of the target. For its removal, superheated steam (at 500
• C) is introduced in the target. On cooling, the condensed water is forced out by a stream of nitrogen and is efficiently collected in a trap. The process is repeated seven times so that > 90% of the activity is accumulated in about 2.5 mL of water.
Chemical processing
There are two major aims of chemical processing:
1. to isolate the desired radionuclide in pure form, 2. to recover the enriched material for reuse. . Radioiodine is collected almost quantitatively and the target is regenerated (without much loss) for the next production run. Thermochromatography, on the other hand, involves the formation of a chemical species of the radioactive product which leads to its removal from the irradiated target but the vapour pressure of which is not high enough to allow its transport to large distances. The activity gets deposited in the cooler part of the thermochromatographic tube from where it is generally removed by rinsing. The method has been successfully employed in the separation of 73 [35] . The thermochromatographic behaviour of a proton-irradiated Cu 3 As-target in an oxygen atmosphere is shown in Fig. 4 [32] . The major radioactive products formed are 73 Se, 74 As and 65 Zn through the nuclear reactions 75 As( p, 3n) 73 Se, 75 As( p, pn) 74 As and 65 Cu( p, n) 65 Zn, respectively. The removal of [ 74 As]As 2 O 3 is carried out at about 660
• C and that of radioselenium at about 1100 • C, while 65 Zn remains in the quartz tube within the oven area. It should, however, be mentioned that thermochromatography only serves to concentrate the desired activity at one point. It does not necessarily give a pure product. For a cleaner separation, a subsequent wet chemical step is often necessary. On the other hand, the recovery of the enriched target material is relatively easy while using distillation or thermochromatography for the separation of the desired radioactive product.
In many production processes a wet chemical procedure is absolutely necessary. Preferentialy solvent extraction and ion-exchange techniques are used but occasionally a prior concentration of the radionuclide is achieved through coprecipitation, adsorption, etc. Several of the emerging radionuclides are separated using these methods. In the production of 64 Cu via the 64 Ni( p, n)-reaction, for example, anion-exchange chromatography was applied [cf . 14]. In the production of 86 Y via the 86 Sr( p, n)-reaction the separation proceeds in two steps [36] . The irradiated enriched 86 SrCO 3 is dissolved in a small volume of conc. HCl and no-carrieradded 86 Y is coprecipitated with La(OH) 3 by addition of NH 4 OH solution. The precipitate is centrifuged off and taken up in a few drops of HCl. The separation of radioyttrium from inactive La is then effected through ion-exchange chromatography by elution with α-hydroxyisobutyric acid, • C to zone (a). The deposition profile was determined using the 595 keV γ -ray of 74 As. (b) Replacement of the external quartz tube by another quartz tube. Removal of radioselenium at 900-1100
• C to zone (a). The activity profile was determined using the 361 keV γ -ray of 73 Se. The volatalized 65 ZnO remains in the quartz tube within the oven area.
either by normal pressure [36] or in combination with high performance liquid chromatography [37] . Fig. 5 shows the elution profile of radioyttrium. The activity amounting to several GBq is collected in only 150 μL solution. The separation of 52 Mn, 52 Fe, 55 Co, 89 Zr, etc. is also carried out via ion-exchange chromatography.
Remote handling
In a real production run the aim is to achieve the maximum batch yield of the radionuclide (with the minimum level of the radionuclidic impurities). The amount of radioactivity involved is rather high (often up to 100 GBq). All the unit operations, such as removal of the irradiated target from the beamline, its transfer to the radiochemistry laboratory, and finally the chemical processing, need to be handled remotely in order to decrease the radiation dose to the researcher. Some of those operations even demand automated methods to avoid human errors. Many of the novel positron emitters are still at the experimental stage of production for local use. On the other hand, a few of them have passed that stage; their large scale production now appears necessary and useful. The examples are: 64 Cu, 86 Y and 124 I. In those cases the need for development of remotely controlled or even automated methods of production is imminent. 86 Y, coprecipitated with La(OH) 3 , was dissolved in a small volume of HCl and transferred to the above column. Elution was done with α-hydroxyisobutyric acid (α-HIB). The 86 Y activity was collected in a few drops (after Ref. [36] ).
Quality control of the product
An important step in a chain of operations for the production of a novel radionuclide consists of quality assurance of the obtained product. In general, four characteristics need to be considered. These are radionuclidic purity, radiochemical purity, chemical purity and specific activity. A brief discussion of each item is given below.
The radionuclidic purity means the absence of any other radionuclide. This is achieved via the choice of a suitable nuclear process and energy range, combined with a clean chemical separation. The radionuclide 124 I, for example can be produced via a large number of reactions [cf . 20]. However, its production is carried out today mainly using the 124 Te( p, n)-reaction on a highly enriched 124 TeO 2 target over the energy range of E p = 14 → 9 MeV. Although the yield of this process is not very high, the resulting product is very pure ( 125 I impurity < 0.1%). The radiochemical purity means that the radiochemically separated product is in the form of one major chemical species. In the case of a solid target the separated radionuclide is generally brought into a desired radiochemical form through oxidation/reduction cycles. The radiochemical purity is generally tested by radiochromatographic methods, such as thin layer chromatography (TLC), e.g. Fig. 6 . The thermochromatographically separated fraction was dissolved in a small volume of 10 −4 M NaOH and the solution subjected to TLC analysis. Two species were detected (Fig. 6a) , one representing TcO 4 − (R f = 0.95) and amounting to 80-90%, and the other a radiochemical impurity (R f ≈ 0) with the contribution of 5-10%. When the solution was passed through a small alumina column, it was purified; the technetium then occurred almost 100% in the chemical form of pertechnetate (Fig. 6b) . −4 M NaOH: (a) original solution, (b) after final purification using alumina column chromatography. S denotes starting point and F the final position. Thin layer chromatography was done on Merck TLC plates (silica gel 60 F 254 ), and acetone was used as solvent system (after Ref. [35] ).
The chemical purity means the absence of inactive impurities which are generally introduced via the chemical reagents used in the production of the radionuclide. Apart from their possible toxicity, those impurities may form complexes with the radionuclide, thereby decreasing its reactivity. The chemical purity appears to be more important in the case of metal radionuclides, such as novel positron emitters, than for radionuclides used in the labelling of organic compounds. For checking the chemical purity one or more of the standard techniques, such as atomic absorption (AA) spectroscopy, ultraviolet (UV) or infrared (IR) detection, inductively coupled plasma-mass spectrometry (ICP-MS) and polarography are used.
The specific activity is defined as the radioactivity per unit mass of the product. Cyclotron production of radionuclides leads inherently to high specific activity products, unless some carrier inadvertently gets introduced by impure target material during the chemical processing stage. The co-production of stable or longer-lived species also needs to be considered since it would decrease the specific activity of the desired product. In case of metal radionuclides it is quite a serious consideration; very pure reagents and clean working methods are absolutely needed. For estimating the specific activity, generally the radioactivity of the whole batch is measured in an ionisation chamber and the mass is determined using a sensitive detection method, such as UV, IR, refractive index or conductivity measurement.
It should be mentioned that the above discussed four quality assurance tests refer to the radionuclide in its original form. They are crucial with respect to further processing of the radionuclide. If the radionuclide is converted into a radiopharmaceutical for human use, several further stringent tests, like those for sterility, apyrogenicity and toxicity, also become mandatory.
Suitability of novel positron emitters for PET imaging
In contrast to standard positron emitters, PET imaging with novel or non-standard positron emitters is often associated with two major problems:
1. High end-point energy of the positron, 2. Emission of γ -rays accompanying the positron.
These may cause reduction of spatial resolution and blurring of the image. PET phantom measurements are therefore needed to demonstrate the suitability of a novel positron emitter for imaging purposes [cf . [38] [39] [40] [41] [42] [43] [44] . The high positron end-point energies of 66 Ga, 76 Br and 120g I (in each case around 4 MeV), for example, limit the use of those radionuclides. Similarly the large number of γ -rays associated with several radionuclides, e.g. 76 Br and 86 Y, cause considersable distortion of images. However, with the development of efficient algorithms these effects can be often efficiently corrected [cf . [38] [39] [40] [41] [42] [43] [44] . Thus, prior to application, the correction factor needs to be determined individually for each novel positron emitter through PET phantom measurements.
Production of novel positron emitters
Several types of accelerators and nuclear reactions have been used for the production of novel radionuclides. A discussion is given below.
Production using low-energy reactions
Most of the novel positron emitters have been developed at laboratories where standard positron emission tomography facilities already existed. Since at PET centres generally only a small-sized cyclotron is available (with E < 20 MeV), almost all of the development work has been carried out using those cyclotrons. A brief overview of the production routes using low-energy reactions is given in Table 1 [cf . 13-19, 28-30, 34-37, 45-50, 53-92] . In each case, except for 45 Ti, 52 Mn, 72 As, 89 Zr and 90 Nb, highly enriched target material was used. The suitable energy range, the thick target yield calculated from the excitation function, the expected radionuclidic impurities and the relevant references are given. For production, in general, solid targetry was used, except for the 38 Ar( p, n) 38 K, 78 Kr( p, α) 75 Br, 78 Kr(d, α) 76 Br and 82 Kr( p, n) 82m Rb reactions where gas targetry was employed. Technical development work has been performed in many institutes around the world but several of the radionuclides have been investigated only in one or two laboratories, with limited application. Radionuclides of more general interest are 55 Co, 61 Cu, 72 As, 76 Br, 89 Zr, 94m Tc and 120g I. Their production methods have been well worked out [cf . 14, 34, 35, 68-70, 81-89] and radionuclidically pure products are available for medical development work. On the other hand, three novel positron emitters, namely 64 Cu, 86 Y and 124 I, have become of wide interest and are now in great demand. Their production is discussed in some detail below.
The radionuclide 64 Cu emits low-energy positrons, has no disturbing γ -ray and has a suitable half-life to study slow metabolic processes. The production route 64 Ni( p, n) 64 Cu, originally suggested by the Jülich group [14], has been further developed in several other laboratories [cf . [45] [46] [47] [48] [49] [50] . In a recent work sophisticated targetry calculations have been done [50] . Batches of about 40 GBq are now routinely produced. Several intermediate energy reactions have also been investigated for the production of 64 Cu [for review cf . 8, 21], but the levels of impurities are higher. Small amounts of 64 Cu can also be produced using the deuteron induced reactions on 64 Zn and nat Zn [cf . 51, 52] . Due to extensive demand for this radionuclide for radioimmunotherapy, attempts are underway to commercialize its production.
The radionuclide 124 I is both a diagnostic and a therapeutic agent. It was originally produced via the 124 Te(d, 2n) 124 I reaction [53] ; accurate cross section data were measured later [54] . Several other reactions have also been investigated [cf . [20] [21] [22] [23] [24] . However, due to the high level of the 125 I (T 1/2 = 60.0 d) impurity associated with those processes, the method 124 Te( p, n) 124 I suggested by our group [19] , was found to be more suitable. With this process the 125 I impurity level is < 0.1%. Today almost all the laboratories use this method [cf . [55] [56] [57] [58] . It involves irradiation of a 124 TeO 2 target and removal of radioiodine by a dry distillation process [cf . 30] . The yield is rather low and the product is somewhat expensive. Nonetheless, due to increasing demands for this radionuclide, efforts are underway to produce this radionuclide in larger qunatities.
The production of 86 Y was also investigated in detail at Jülich and the reaction 86 Sr( p, n) 86 Y was found to be the most suitable [17, 36, 37] . The irradiated 86 SrCO 3 target was dissolved in a small volume of conc. HCl and the separation of radioyttrium was carried out, as mentioned above, by coprecipitation followed by ion-exchange [36] ; later in combination with HPLC [37] . Four other methods of separation have also been applied: one involves electrolysis [59, 90, 91] , the other one multiple column chromatography [60] , the third one solvent extraction [cf . 61] , and the fourth one a simple precipitation of the target material [62, 92] . The electrolytic method appears to be more promising. The radionuclide 86 Y obtained has a purity of about 99%. The target material 86 Sr is recovered easily and, since the suggested proton energy of 14 MeV is below the threshold of the 86 Sr( p, pn) 85 Sr reaction, the recovered target material is free of any radioactive impurity. In contrast, the intermediate energy reactions used for the production of 86 90 Y-labelled therapeuticals. The demand for this radionuclide is also increasing and so its large scale production is being planned at several centres.
Production using intermediate energy reactions
Despite the above discussed capability of low-energy nuclear reactions on highly enriched target isotopes to produce many novel positron emitters there are some radionuclides which can be produced exclusively or alternatively using intermediate-energy reactions. A list of those radionuclides is given in 64 Cu. The ( p, 2n) reaction can generally be performed at a 30 MeV cyclotron. For other reactions, higher proton energies, in some cases up to 100 MeV, are needed. With the emission of a large number of nucleons, the nuclear data work becomes rather extensive. As a typical example, the excitation functions of several measured reactions in the interaction of protons with 85 Rb [123] are shown in Fig. 7 . Evidently, for the production of a desired radionuclide, a narrow energy window has to be chosen. In the example given above, the suitable energy range for the production of the novel positron emitter 83 Sr amounts to E p = 38 → 30 MeV. Similarly, the radionuclide 82 Sr (the parent nuclide used in the preparation of the standard 82 Sr/ 82 Rb generator system) is advantageously produced over the energy range of E p = 70 → 50 MeV.
Although in the intermediate energy region mostly protons are available and are also preferably used, other charged particles like deuterons, 3 He-and α-particles may also induce a few useful reactions. For example, the intermediate energy deuterons could be useful in the production of 64 76 Br reactions, respectively, because of the difficulty in target construction while using enriched 76 Se. In some other cases, e.g. 52 Fe, 77 Kr, 83 Sr, 86 Y and 94m Tc, the use of the 3 He-particle beam is optional, the yield being lower than that using the corresponding ( p, xn) reaction. As far as the α-particle beam is concerned, to date the radionuclides 30 P and 38 K have been exclusively produced in GBq amounts by an (α, n) reaction [cf . 124, 125] . In case of non-availability of 40 MeV protons, the utility of the 70 Ge(α, n) 73 Se reaction in the production of 73 Se in GBq amounts has also been demonstrated [31] . The use of the nat Cu(α, x) 66 Ga and nat Sr(α, x) 89 Zr reactions to produce 66 Ga and 89 Zr is again optional [115, 133] , since the yields of the commonly used 66 Zn( p, n) 66 Ga and 89 Y( p, n) 89 Zr processes are much higher. The possibility of production of 82 Sr via the 82 Kr(α, 4n) 82 Sr reaction has also been investigated [126] . Though less effective, Fig. 7 . Excitation functions of proton induced nuclear reactions on 85 Rb. (a) 85 Rb( p, xn)-reactions leading to the formation of the radionuclides 85 Sr, 83 Sr, 82 Sr and 81 Sr. (b) 85 Rb( p, pxn)-reactions giving rise to the radionuclides 84 Rb, 83 Rb, 82 Rb and 81 Rb. The experimental data [112, 123] are shown as eye-guide solid curves and the results of calculations using the nuclear reaction model code ALICE-IPPE [123] as dotted curves. With increasing projectile energy the number of radioactive products formed increases considerably.
it could be an alternative method to the 85 Rb( p, 4n) 82 Sr process if the available proton energy is below 70 MeV. Very recently the 123 Sb(α, 3n) 124 I reaction was carefully studied [122] and it was concluded that irradiation of 123 Sb with 45 MeV α-particles, especially in a parasitic position, could lead to appreciable quantities of the radionuclide 124 I.
The above discussion shows that intermediate energy cyclotrons have great potential for production of novel positron emitters. For most of the listed radionuclides, sufficient quantities for medical applications have been produced. However, a critical look at the various processes is necessary. The radionuclides 30 P and 38 K are short-lived and can only be locally used. The radionuclides 52 Mn, 55 Co, 64 Cu, 66 Ga, 76 Br, 86 Y, 89 Zr, 94m Tc and 120g I produced via intermediate energy reactions (cf . Table 2 and also Refs. [127] [128] [129] [130] ) often contain larger radionuclidic impurities than in the case of low-energy production reactions, so that their preferred routes are those given in Table 1 . This has been clearly demonstrated in the case of 55 Co, 86 86 Y and of 120m I in 120g I is much higher. On the other hand, the production of the radionuclides 52 Fe, 73 Se, 77 Kr and 83 Sr demands a high intensity cyclotron, accelerating protons up to about 70 MeV (in the case of 52 Fe preferably up to 100 MeV). Furthermore, the production of 124 I via the 125 Te( p, 2n)-reaction deserves more attention. The 125 Iimpurity level of 0.7% in this process [121] is higher than that of < 0.1% in the 124 Te( p, n)-process [19] , but the yield of 124 I is by a factor of about six higher. Thus more efforts need to be invested in intermediate energy reactions to make better use of production possibilities of some novel positron emitters. 68 Ge and 82 Sr appears to be adequate. However, due to enhancing interest in 68 Ga-radiopharmaceuticals, more efforts related to 68 Ge production and an efficient generator column preparation may soon be called for. Furthermore, since the half-life of 68 Ga is not very short, its direct pro- Some other generator systems have also been proposed (for a review of production routes cf . [131, 132] ). A few interesting systems for furnishing some novel positron emitters are listed in Table 3 . They are discussed in some detail below. The systems 52 Fe/ 52m Mn, 62 Zn/ 62 Cu and 122 Xe/ 122 I were proposed rather long time ago. Out of those, more detailed studies have been carried out only on the system 62 Zn/ 62 Cu. In general not much progress has been reported regarding their further applications. This is mainly due to the short half-lives of the parents, combined with the difficulties in their production. Although the 62 Zn parent nuclide can be produced with 30 MeV protons [cf . 133], the production of 52 Fe and 122 Xe demands higher energies [97, 135, 136] . Another reason for the limited use of those systems is the relatively short half-life of the daughter positron emitter.
Production of novel parent generator radionuclides
The generator systems 72 Se/ 72 As and 140 Nd/ 140 Pr have great potential, the former for studying the biological behaviour of arsenic and the latter as an in vivo generator, if the Auger electron emitter 140 Nd is used in endoradiotherapy. The yield of the parent radionuclide 72 Se is rather low [cf . 102, 103] . Nonetheless two generator systems for obtaining the daughter 72 As, one based on distillation [137] and the other one on solid phase extraction [138] have been developed. With regard to 140 Nd, the ( p, 2n) and ( 3 He, xn) reactions on 141 Pr and nat Ce, respectively, have been investigated in detail [cf . 139]. As expected, the former reaction leads to a much higher yield. A generator system based on physico-chemical transitions in 140 Pr complexes has also been described [cf . 140] .
The generator system 44 Ti/ 44 Sc has received some attention in recent years. Due to the long half-life of 60.4 years of the parent, it is rather difficult to produce. Furthermore, there may be some regulatory problems in the introduction of this very long-lived system. Nonetheless, from the scientific and application point of view (see below), it appears worthwhile to develop it further. The suggested production reaction is 45 Sc( p, 2n) 44 Ti and the excitation function, recently measured [141] , is reproduced in Fig. 8 . Evidently the cross section is not very high, which is qualitatively understandable, because the emission of two 45 Sc( p, 2n) 44 Ti and nat Ga( p, xn) 68 Ge used to induce the parent activities for preparation of the radionuclide generator systems 44 Ti/ 44 Sc and 68 Ge/ 68 Ga. The data for the former reaction are reproduced from Ref. [141] and those for the latter from Ref. [142] .
neutrons in the interaction of a proton with a relatively light mass nucleus, such as 45 68 Ge process. The excitation function for the formation of 68 Ge has a slightly lower threshold and an order of magnitude higher cross section than the 45 Sc( p, 2n) 44 Ti reaction. Thus there is little analogy between the two reactions. The production of 68 Ge is routinely done. In the case of 44 Ti, to date a 185 MBq generator has been reported [143] and some post-elution purification of 44 Sc has been described [144] . Higher current targetry and long irradiation periods will be called for to obtain higher yields.
Applications of novel positron emitters
The applications of novel positron emitters are manifold [cf . 4]. A detailed discussion is beyond the scope of this article; therefore, only the three major areas of application are briefly mentioned. 55 Co (T 1/2 = 17.6 h), 72 As (T 1/2 = 26.0 h), 73 Se (T 1/2 = 7.1 h), and 124 I (T 1/2 = 4.18 d). When attached to proper organic compounds, they could be used for detection of tumor, neuronal damage or organ functional deficiency. The slow uptake kinetics by an organ can be conveniently and quantitatively followed using a longer lived positron emitter and positron emission tomography.
With regard to quantification of SPECT-radiopharmaceuticals, an analogue approach is needed, which involves the use of a positron emitting nuclide of the chemical element of the SPECT radionuclide. Thus for quantification of a 99m Tc-radiopharmaceutical, labelling can be done using the positron emitting radionuclide 94m Tc (T 1/2 = 52 min) followed by a PET measurement. This way the 99m Tc-based SPECT flow agent terboroxime (CardioTec) was labelled with 94m Tc for quantitative PET investigation [cf . 145], Similarly, 94m Tc has been applied in studies related to changes in dopamine transporter concentrations (e.g. with TRODAT-1) [146] .
A very significant application of non-standard longer lived positron emitters is in therapy planning. Since dosimetry in endotherapy with purely β − emitting radionuclides like 90 Y (T 1/2 = 2.7 d) has a rather large uncertainty, a mixture of the β + emitting 86 Y (T 1/2 = 14.7 h) and the therapeutic radionuclide 90 Y was used [147] . The uptake kinetics were determined by PET imaging of 86 Y, and the results were used in an accurate dosimetric calculation. This concept is now finding increasing application. Another radionuclide investigated is 83 Sr (T 1/2 = 32.2 h) which can be combined with the purely β − emitting therapeutic radionuclide 89 Sr (T 1/2 = 50.0 d). The dosimetry in the case of the most commonly used therapeutic radionuclide 131 I (T 1/2 = 8.0 d) is fairly well established. However, if a PET study using 124 I precedes the use of 131 I, the dosimetric calculations can be done even more precisely. A further advantage of 124 I is that it could itself be used as a therapeutic agent. Because of the combination of PET and endoradiotherapy, allowing precise dosimetry, this radionuclide is superior to the commonly used reactor radionuclide 131 I. The cost of 124 I, however, is higher than that of 131 I. In recent years, the importance of metallic positron emitters in quantification of radioimmunotherapy has been increasing. Radionuclides such as 67 Cu (T 1/2 = 2.6 d), 67 Ga (T 1/2 = 3.3 d) and 111 In (T 1/2 = 2.8 d) can be attached to monoclonal antibodies (mAB) leading to therapeutic effects through interactions of β − particles or Auger electrons with the tissue. The use of the respective positron emitting radionuclides 64 Cu (T 1/2 = 12.7 h), 68 Ga (T 1/2 = 67.6 min) and 110g In (T 1/2 = 1.1 h) allows PET imaging for quantification purposes. In particular, the radionuclide 64 Cu (with multiple decay mode) has proved to be very suitable for combining PET imaging and targeted therapy [cf . 148].
Conclusions and perspectives
Radionuclide production technology at cyclotrons has been well developed, especially for short-lived organic positron emitters. In this regard, all components of the technology, i.e., special purpose cyclotron, high current irradiation target and automated or remotely controlled chemical processing unit can now be commercially purchased. Furthermore, two radionuclide generator systems providing short-lived positron emitters ( 68 Ga and 82 Rb) are supplied by several companies, though the parent nuclides are produced through intermediate energy nuclear reactions only at a few large research centres.
In contrast to the commonly used positron emitters, a few other longer lived positron emitting radionuclides, having passed the stage of laboratory scale production and clinical evaluation, are now in great demand, but are not easily available. A few examples are 64 Cu, 86 Y and 124 I. They are produced using highly enriched target material but low energy cyclotrons, whereby the radionuclidic purity is high but the yield is low. Efforts are therefore underway in commercially oriented laboratories to increase the production yields of those radionuclides and thus to ensure their availability on a broader scale.
The number of positron emitters potentially interesting for medical applications is relatively large. They are research type radionuclides and the development work needed is rather heavy, calling for investigations in many directions, starting from nuclear data measurements, proceeding through high current target construction and chemical processing, and leading up to quality control of the final product. Similar to the three novel positron emitters mentioned above, in many cases a combination of isotopically enriched target material and a small-sized cyclotron may be sufficient for production. However, for production of many new nuclides high intensity intermediate energy cyclotrons have great potential. This appears to be particularly true for metallic positron emitters used in combination with a longer lived β − emitter or Auger electron emitter for radioimmunotherapy. The four pairs, namely 44 Sc/ 47 Sc, 64 Cu/ 67 Cu, 68 Ga/ 67 Ga and 110g In/ 111 In, could be developed further with the availability of a new generation high power accelerator having proton energies up to 100 MeV. In general it is concluded that the field of cyclotron production of medical radionuclides is flourishing and that many new impulses are expected within the next few years, especially with regard to the use of novel positron emitters and therapeutic radionuclides.
